These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 26999745)
1. In vitro inhibitory activity of probiotic products against oral Candida species. Zhao C; Lv X; Fu J; He C; Hua H; Yan Z J Appl Microbiol; 2016 Jul; 121(1):254-62. PubMed ID: 26999745 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of probiotic lactobacilli supernatants on single and mixed non-albicans Candida species biofilm. Tan Y; Leonhard M; Moser D; Ma S; Schneider-Stickler B Arch Oral Biol; 2018 Jan; 85():40-45. PubMed ID: 29031236 [TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory mechanism of Bacillus subtilis R0179 in RAW 264.7 cells against Candida albicans challenge. Zhao W; Wang X; Zhao C; Yan Z Microb Pathog; 2021 Aug; 157():104988. PubMed ID: 34044051 [TBL] [Abstract][Full Text] [Related]
4. Screening of Bacillus strains as potential probiotics and subsequent confirmation of the in vivo effectiveness of Bacillus subtilis MA139 in pigs. Guo X; Li D; Lu W; Piao X; Chen X Antonie Van Leeuwenhoek; 2006 Aug; 90(2):139-46. PubMed ID: 16820971 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Bacillus subtilis R0179 on gastrointestinal viability and general wellness: a randomised, double-blind, placebo-controlled trial in healthy adults. Hanifi A; Culpepper T; Mai V; Anand A; Ford AL; Ukhanova M; Christman M; Tompkins TA; Dahl WJ Benef Microbes; 2015 Mar; 6(1):19-27. PubMed ID: 25062611 [TBL] [Abstract][Full Text] [Related]
6. Postharvest Biological Control of Colletotrichum acutatum on Apple by Bacillus subtilis HM1 and the Structural Identification of Antagonists. Kim HM; Lee KJ; Chae JC J Microbiol Biotechnol; 2015 Nov; 25(11):1954-9. PubMed ID: 26428548 [TBL] [Abstract][Full Text] [Related]
7. Antagonistic effects of Bacillus subtilis subsp. subtilis and B. amyloliquefaciens against Macrophomina phaseolina: SEM study of fungal changes and UV-MALDI-TOF MS analysis of their bioactive compounds. Torres MJ; Brandan CP; Petroselli G; Erra-Balsells R; Audisio MC Microbiol Res; 2016 Jan; 182():31-9. PubMed ID: 26686611 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory activity in vitro of probiotic lactobacilli against oral Candida under different fermentation conditions. Jiang Q; Stamatova I; Kari K; Meurman JH Benef Microbes; 2015; 6(3):361-8. PubMed ID: 25380800 [TBL] [Abstract][Full Text] [Related]
10. Antifungal activity of clinical Lactobacillus strains against Candida albicans biofilms: identification of potential probiotic candidates to prevent oral candidiasis. Rossoni RD; de Barros PP; de Alvarenga JA; Ribeiro FC; Velloso MDS; Fuchs BB; Mylonakis E; Jorge AOC; Junqueira JC Biofouling; 2018 Feb; 34(2):212-225. PubMed ID: 29380647 [TBL] [Abstract][Full Text] [Related]
11. Bacillus subtilis subsp. subtilis CBMDC3f with antimicrobial activity against Gram-positive foodborne pathogenic bacteria: UV-MALDI-TOF MS analysis of its bioactive compounds. Torres MJ; Petroselli G; Daz M; Erra-Balsells R; Audisio MC World J Microbiol Biotechnol; 2015 Jun; 31(6):929-40. PubMed ID: 25820813 [TBL] [Abstract][Full Text] [Related]
12. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry. Aslani N; Janbabaei G; Abastabar M; Meis JF; Babaeian M; Khodavaisy S; Boekhout T; Badali H BMC Infect Dis; 2018 Jan; 18(1):24. PubMed ID: 29310582 [TBL] [Abstract][Full Text] [Related]
13. Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study. de Castro RD; de Souza TM; Bezerra LM; Ferreira GL; Costa EM; Cavalcanti AL BMC Complement Altern Med; 2015 Nov; 15():417. PubMed ID: 26601661 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory activity of probiotic Bacillus subtilis UTM 126 against vibrio species confers protection against vibriosis in juvenile shrimp (Litopenaeus vannamei). Balcázar JL; Rojas-Luna T Curr Microbiol; 2007 Nov; 55(5):409-12. PubMed ID: 17680306 [TBL] [Abstract][Full Text] [Related]
15. [A comparative study of the biological properties of Biosporin and other commercial Bacillus-based preparations]. Sorokulova IB Mikrobiol Z; 1997; 59(6):43-9. PubMed ID: 9511375 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Lipopolysaccharide-Induced Interleukin 8 in Human Adenocarcinoma Cell Line HT-29 by Spore Probiotics: B. coagulans and B. subtilis (natto). Azimirad M; Alebouyeh M; Naji T Probiotics Antimicrob Proteins; 2017 Mar; 9(1):56-63. PubMed ID: 27785697 [TBL] [Abstract][Full Text] [Related]
17. Effect of lipopeptides of antagonistic strains of Bacillus subtilis on the morphology and ultrastructure of the cucurbit fungal pathogen Podosphaera fusca. Romero D; de Vicente A; Olmos JL; Dávila JC; Pérez-García A J Appl Microbiol; 2007 Oct; 103(4):969-76. PubMed ID: 17897200 [TBL] [Abstract][Full Text] [Related]
18. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance. Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027 [TBL] [Abstract][Full Text] [Related]
19. [Influence of lactitol and lactulose on adhesion properties of Bacillus subtilis probiotic strains]. Avdeeva LV; Osadchaia AI; Kharkhota MA Mikrobiol Z; 2012; 74(5):22-5. PubMed ID: 23120982 [TBL] [Abstract][Full Text] [Related]
20. Protection activity of a novel probiotic strain of Bacillus subtilis against Salmonella Enteritidis infection. Thirabunyanon M; Thongwittaya N Res Vet Sci; 2012 Aug; 93(1):74-81. PubMed ID: 21907374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]